Moncrieff, Joanna, 1966-...
Joanna Moncrieff British psychiatrist
Moncrieff, Joanna.
VIAF ID: 58541609 (Personal)
Permalink: http://viaf.org/viaf/58541609
Preferred Forms
- 100 0 _ ‡a Joanna Moncrieff ‡c British psychiatrist
- 200 _ | ‡a Moncrieff ‡b Joanna ‡f 1966-....
- 100 1 _ ‡a Moncrieff, Joanna
-
-
- 100 1 _ ‡a Moncrieff, Joanna ‡d 1966-
- 100 1 _ ‡a Moncrieff, Joanna ‡d 1966-
- 100 1 _ ‡a Moncrieff, Joanna ‡d 1966-...
- 100 1 _ ‡a Moncrieff, Joanna, ‡d 1966-
-
-
-
- 100 1 _ ‡a Moncrieff, Joanna, ‡d 1966-
-
- 100 1 _ ‡a Moncrieff, Joanna, ‡d 1966-...
-
4xx's: Alternate Name Forms (12)
5xx's: Related Names (1)
Works
Title | Sources |
---|---|
Active placebos versus antidepressants for depression | |
Against the stream: Antidepressants are not antidepressants - an alternative approach to drug action and implications for the use of antidepressants. | |
Antipsychotic Maintenance Treatment: Time to Rethink? | |
Antipsychotics as particular types of sedatives | |
Association between sexual and substance abuse | |
Attention deficit hyperactivity disorder late birthdate effect common in both high and low prescribing international jurisdictions: systematic review | |
Author's reply | |
The bitterest pills : the troubling story of antipsychotic drugs | |
British psychiatry in the 20th century--observations from a psychiatric journal | |
Claims for sickness and disability benefits owing to mental disorders in the UK: trends from 1995 to 2014 | |
Clinical trials and the response rate illusion | |
Clozapine v. conventional antipsychotic drugs for treatment-resistant schizophrenia: a re-examination | |
The costs incurred by the NHS in England due to the unnecessary prescribing of dependency-forming medications | |
The creation of the concept of an antidepressant: an historical analysis | |
A critical analysis of recent data on the long-term outcome of antipsychotic treatment | |
Czy psychiatria jest na sprzedaż? : o wpływie przemysłu farmaceutycznego na psychiatrię akademicką i praktykę psychiatryczną | |
Double blind random bluff. | |
Drop the language of disorder | |
Drug-centred psychopharmacology : a non-diagnostic framework for drug treatment | |
Drugs versus placebo for dysthymia | |
Efficacy of antidepressants in adults | |
Empirically derived criteria cast doubt on the clinical significance of antidepressant-placebo differences | |
Experiences of taking neuroleptic medication and impacts on symptoms, sense of self and agency: a systematic review and thematic synthesis of qualitative data | |
Forty years of lithium treatment | |
The functions of an asylum: an analysis of male and female admissions to Essex County Asylum in 1904 | |
Hipoteza neuroprotekcyjna : czy farmakoterapia zapobiega uszkodzeniu mózgu we wczesnej psychozie lub schizofrenii | |
History, violence and collective memory: Implications for mental health in Ecuador | |
Inconclusive Evidence in Support of the Dopamine Hypothesis of Psychosis: Why Neurobiological Research Must Consider Medication Use, Adjust for Important Confounders, Choose Stringent Comparators, and Use Larger Samples. | |
Is ADHD a valid diagnosis in adults? No. | |
Is the chemical imbalance an ‘urban legend’? An exploration of the status of the serotonin theory of depression in the scientific literature | |
Krytyczna analiza koncepcji nadpobudliwości psychoruchowej z zaburzeniami uwagi u dorosłych | |
Lack of safeguards in response to restrictive public health measures | |
The least worst option: user experiences of antipsychotic medication and lack of involvement in medication decisions in a UK community sample. | |
Lithium revisited. A re-examination of the placebo-controlled trials of lithium prophylaxis in manic-depressive disorder | |
Magic bullets for mental disorders: the emergence of the concept of an "antipsychotic" drug | |
The medicalisation of "ups and downs": the marketing of the new bipolar disorder. | |
De-medicalizing misery II Society, politics and the mental health industry | |
De-medicalizing misery : psychiatry, psychology and the human condition | |
Mental health professionals' views and experiences of antipsychotic reduction and discontinuation. | |
Misleading information about antipsychotics | |
Misrepresenting harms in antidepressant trials. | |
Modernising mental health services. Psychiatrists should oppose community treatment orders | |
Myth of the chemical cure : a critique of psychiatric drug treatment | |
n2007185598 | |
New drug treatments for alcohol problems: a critical appraisal | |
The pharmaceutical industry and disease mongering. Psychiatry should not accept so much commercial sponsorship | |
Protecting physical health in people with mental illness | |
Psychiatric drug promotion and the politics of neo-liberalism. | |
Psychiatry beyond the current paradigm. | |
The psychoactive effects of antidepressants and their association with suicidality | |
The psychoactive effects of psychiatric medication: the elephant in the room | |
Psychosocial interventions for people with schizophrenia or psychosis on minimal or no antipsychotic medication: A systematic review | |
Psykiatriske legemidler : en kritisk introduksjon | |
Psykologisering av sosiale problemer, medikalisering av psykiske lidelser | |
The quality of alcohol treatment research: an examination of influential controlled trials and development of a quality rating system. | |
Questioning the 'neuroprotective' hypothesis: does drug treatment prevent brain damage in early psychosis or schizophrenia? | |
Quetiapine immediate release v. placebo for schizophrenia: systematic review, meta-analysis and reappraisal | |
Randomised controlled trial of gradual antipsychotic reduction and discontinuation in people with schizophrenia and related disorders: the RADAR trial (Research into Antipsychotic Discontinuation and Reduction) | |
Recruitment and retention strategies in mental health trials - A systematic review | |
REDUCE (Reviewing long-term antidepressant use by careful monitoring in everyday practice) internet and telephone support to people coming off long-term antidepressants: protocol for a randomised controlled trial | |
Research on a 'drug-centred' approach to psychiatric drug treatment: assessing the impact of mental and behavioural alterations produced by psychiatric drugs. | |
Results of a pilot cluster randomised trial of the use of a Medication Review Tool for people taking antipsychotic medication. | |
Rethinking models of psychotropic drug action | |
Schizophrenia: a critical psychiatry perspective | |
Selective serotonin reuptake inhibitors: evidence base for older antidepressants is shaky too. | |
The serotonin hypothesis of depression: both long discarded and still supported? | |
The serotonin theory of depression: a systematic umbrella review of the evidence | |
Sexual abuse in people with alcohol problems. A study of the prevalence of sexual abuse and its relationship to drinking behaviour. | |
The social and cultural construction of psychiatric knowledge: an analysis of NICE guidelines on depression and ADHD. | |
The social underpinnings of mental distress in the time of COVID-19 - time for urgent action | |
Some progress in UK psychiatry | |
SSRI and SNRI withdrawal symptoms reported on an internet forum | |
Straight talking introduction to psychiatric drugs : the truth about how they work and how to come off them | |
The subjective experience of taking antipsychotic medication: a content analysis of Internet data | |
Supporting antidepressant discontinuation: the development and optimisation of a digital intervention for patients in UK primary care using a theory, evidence and person-based approach | |
A systematic review of the effects of antipsychotic drugs on brain volume | |
Trends in prescriptions and costs of drugs for mental disorders in England, 1998-2010. | |
Trendy w przepisywaniu oraz koszt leków stosowanych w zaburzeniach psychicznych w Anglii w latach 1998-2010 | |
What does the latest meta-analysis really tell us about antidepressants? | |
Why is it so difficult to stop psychiatric drug treatment? It may be nothing to do with the original problem | |
精神科の薬について知っておいてほしいこと : 作用の仕方と離脱症状 |